How JBC sold its Soul to the Devil
All good things come to an end.
Tag: cancer research
Get fit with the microRNA Diet
Smut Clyde tries to understand how dietary miRNAs are supposed to work, and gives up. A story with three openings and no ending.
The scientific sea of miR- and exosome-related knowledge
“Whole cohorts of peer-reviewers have been trained to view all these mannerist stylings as what western blots should look like. […] It will be a challenge to convince them otherwise.” – Smut Clyde.
Schneider Shorts 17.09.2021 – A Face to Punch
Schneider Shorts 17.09.2021: Claudio Hetz and Arati Ramesh without intent to commit fraud, a competition of stupidity – featuring Tel Aviv University, French Minister for Research, entire pharma giant Sanofi, and everyone following a certain Church, and finally: can one punch a bearded guy wearing glasses (asking for a friend)?
Send in the Senolytics!
“The authors declare no competing financial interests.”
Cell Cycle of Angry Axe-Wielding Tribbles
“For the most competitive papers, an ultra-rapid review (by members of the Editorial Board) is necessary to publish them a few days after submission.”, Misha Blagosklonny, on how his journals became papermill fraud bonanza
Schneider Shorts 30.07.2021: The Pigs Did It!
Schneider Shorts 30.07.2021: shitty antivaxxery, innovative cancer cures, the REAL cause of global warming, Sputnik V goes over 100%, journalists discover find the new Galileo reincarnation, and don’t you also just hate those medicinal regulatory authorities?
La Piovra Ferrarese di Giorgio Zauli
Giorgio Zauli’s rectorship term ends. Will research fraud, media harassment and whistleblower persecution be a thing of the past at the University of Ferrara? Ma dai, basta cazzate.
Nanotheranostics with a decisive action
“We will look in each instance thoroughly and take a decisive action in consultation with journals and university in each instance as appropriate”, Sasha Kabanov, winner of the Lenin Komsomol Prize 1988
How to cure all diseases
“I have a passion to solve a problem that is facing millions. I could have a job that makes more money, has normal hours, but this is where I should be right now.” Dr Leen Kawas, CEO of Althira Pharma
For Better Science 